1,721,061 research outputs found
sj-docx-1-msj-10.1177_13524585231189673 – Supplemental material for Assessing heterogeneity of treatment effect in multiple sclerosis trials
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatment effect in multiple sclerosis trials by Maria Pia Sormani, Jeremy Chataway, David M Kent and Ruth Ann Marrie in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585221124043 – Supplemental material for The mSteps pilot study: Analysis of the distance walked using a novel smartphone application in multiple sclerosis
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585221124043 for The mSteps pilot study: Analysis of the distance walked using a novel smartphone application in multiple sclerosis by Sarah Alexander, Marie Braisher, Carmen Tur and Jeremy Chataway in Multiple Sclerosis Journal</p
sj-docx-2-msj-10.1177_13524585231189673 – Supplemental material for Assessing heterogeneity of treatment effect in multiple sclerosis trials
No full textSupplemental material, sj-docx-2-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatment effect in multiple sclerosis trials by Maria Pia Sormani, Jeremy Chataway, David M Kent and Ruth Ann Marrie in Multiple Sclerosis Journal</p
MSJ794063_supplementary_material – Supplemental material for Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials
No full textSupplemental material, MSJ794063_supplementary_material for Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials by Richard S Nicholas, Erika Han, Joel Raffel, Jeremy Chataway and Tim Friede in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585231164296 – Supplemental material for Management of vascular risk in people with multiple sclerosis at the time of diagnosis in England: A population-based study
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231164296 for Management of vascular risk in people with multiple sclerosis at the time of diagnosis in England: A population-based study by Raffaele Palladino, Ruth Ann Marrie, Azeem Majeed and Jeremy Chataway in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585231189677 – Supplemental material for Enhancing diversity of clinical trial populations in multiple sclerosis
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231189677 for Enhancing diversity of clinical trial populations in multiple sclerosis by Ruth Ann Marrie, Jeremy Chataway, Barbara E Bierer, Marcia Finlayson, Elena H Martinez-Lapiscina, Jennifer Panagoulias, Maria Pia Sormani, Mitzi Joi Williams and Lilyana Amezcua in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585231189678 – Supplemental material for Enhancing involvement of people with multiple sclerosis in clinical trial design
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231189678 for Enhancing involvement of people with multiple sclerosis in clinical trial design by Emma Gray, Anneesa Amjad, Jenny Robertson, Judy Beveridge, Susan Scott, Guy Peryer, Marie Braisher, Cheryl Pugh, Sara Peres, Ruth Ann Marrie, Maria Pia Sormani and Jeremy Chataway; in Multiple Sclerosis Journal</p
sj-docx-2-msj-10.1177_13524585231189678 – Supplemental material for Enhancing involvement of people with multiple sclerosis in clinical trial design
No full textSupplemental material, sj-docx-2-msj-10.1177_13524585231189678 for Enhancing involvement of people with multiple sclerosis in clinical trial design by Emma Gray, Anneesa Amjad, Jenny Robertson, Judy Beveridge, Susan Scott, Guy Peryer, Marie Braisher, Cheryl Pugh, Sara Peres, Ruth Ann Marrie, Maria Pia Sormani and Jeremy Chataway; in Multiple Sclerosis Journal</p
sj-docx-2-msj-10.1177_13524585231189671 – Supplemental material for Improving the efficiency of clinical trials in multiple sclerosis
No full textSupplemental material, sj-docx-2-msj-10.1177_13524585231189671 for Improving the efficiency of clinical trials in multiple sclerosis by Ruth Ann Marrie, Maria Pia Sormani, Sean Apap Mangion, Francesca Bovis, Winson Y Cheung, Gary R Cutter, Peter Feys, Michael D Hill, Marcus Werner Koch, Morgan McCreary, Ellen M Mowry, Jay JH Park, Fredrik Piehl, Amber Salter and Jeremy Chataway in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585231189671 – Supplemental material for Improving the efficiency of clinical trials in multiple sclerosis
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231189671 for Improving the efficiency of clinical trials in multiple sclerosis by Ruth Ann Marrie, Maria Pia Sormani, Sean Apap Mangion, Francesca Bovis, Winson Y Cheung, Gary R Cutter, Peter Feys, Michael D Hill, Marcus Werner Koch, Morgan McCreary, Ellen M Mowry, Jay JH Park, Fredrik Piehl, Amber Salter and Jeremy Chataway in Multiple Sclerosis Journal</p
- …
